Revvity | Fremdkapital



Loan Capital Veränderung Datum
Adcock Ingram Holdings ZAR 238.08M 21.45M 2024-06
Agilent USD 3.35B 2M 2025-01
Align Technology USD 0 0 2024-12
Bio Techne USD 300M 0 2024-12
Bio-Rad Laboratories USD 1.2B 338K 2024-12
Bruker USD 2.06B 202.7M 2024-12
Celltrion KRW 79.58B 21.94B 2024-09
Charles River Laboratories USD 2.24B 86.45M 2024-12
Cspc Pharmaceutical CNY 66.32M 40.74M 2024-06
Danaher USD 15.5B 824M 2024-12
Dentsply International USD 1.59B 209M 2024-12
Dianthus Therapeutics USD 0 0 2024-09
Ecofibre AUD 9.5M 0 2024-06
Edwards Lifesciences USD 597.7M 200K 2024-12
Exact Sciences USD 2.33B 23K 2024-12
Hologic USD 2.49B 19M 2024-12
Illumina USD 1.49B 498M 2024-12
Intuitive Surgical USD 0 0 2024-12
IQVIA Holdings USD 12.84B 545M 2024-12
Kangmei Pharma CNY 169.19M 7.26M 2024-09
Knight Therapeutics CAD 36.51M 2.04M 2024-09
Laboratorios Farma EUR 98.14M 45.9M 2024-06
Laboratory Of America USD 5.41B 21.8M 2024-12
Malin Corporation EUR 0 0 2024-06
Medical Developments International AUD 1.91M 146K 2024-06
Mettler Toledo International USD 1.83B 60.4M 2024-12
Myriad Genetics USD 39.6M 600K 2024-12
Neuren Pharmaceuticals AUD 0 0 2024-12
Organigram Holdings CAD 43.29M 12.19M 2024-12
Patterson Companies USD 321.76M 3.63M 2025-01
Pharma Mar EUR 41.23M 999K 2024-12
Qiagen NV USD 1.34B 26.51M 2024-12
Quest Diagnostics USD 5.62B 33M 2024-12
Quidel USD 2.14B 35.3M 2024-12
Repligen USD 521.61M 3.89M 2024-09
Revvity USD 3.15B 35.22M 2024-12
Sartorius EUR 4.43B 106.8M 2024-09
Sino Biopharmaceutical CNY 1.16B 90.25M 2024-06
Thermo Fisher Scientific USD 29.06B 2.14B 2024-12
Tilray USD 316.63M 15.02M 2024-11
Waters USD 1.63B 199.76M 2024-12
Zz Pientze Pharmaceu 162.42M 4.3M 2024-09



Revvity Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.